Buy These 3 Nationwide Mutual Funds for Long-Term Gains

Zacks highlighted three Nationwide mutual funds as long-term buys based on Strong Buy/Buy rankings, positive multiyear returns and comparatively low expense ratios. NWAMX posted 3-year and 5-year annualized returns of 17.7% and 13.5% with a 0.70% expense ratio; NWHJX returned 19.8% and 11.1% with a 1.04% expense ratio; and GAFRX returned 15.5% and 8.5% with a 0.83% expense ratio. The recommendation is fund-specific analyst commentary and is unlikely to materially affect broader markets.

Analysis

This is not a meaningful information event for the underlying equities: the cited vehicles are small retail mutual funds, and rating/ranking methodology is backward-looking rather than a new fundamental catalyst. Any incremental flows are unlikely to affect liquidity or valuation in UNH, CSCO, TXN, ASML, AZN, or NVS. The more relevant read-through is factor exposure: the domestic vehicle is effectively a quality/value tilt, while the international vehicle embeds a concentrated semiconductor-capex position through ASML alongside defensive pharma exposure.

ASML is the only holding where concentration could matter to a portfolio-level interpretation. A sustained rotation into developed ex-US active funds would reinforce demand for ASML, but its earnings multiple remains far more sensitive over 1-3 months to foundry capex orders, export-control developments, and EUV shipment timing than to fund-selection publicity. Pairing ASML against a broad international ETF would isolate the AI-capex thesis, while pairing it against AZN/NVS can reduce broad foreign-exchange and regional equity beta.

The contrarian point is that the advertised low-fee framing is weak: active mutual-fund expense ratios remain substantially above broad ETFs, creating little reason to expect durable new flows absent platform distribution data. Six- to eighteen-month performance dispersion will be driven by whether value/defensive exposures continue to lag AI infrastructure; a renewed rates decline and capex acceleration would likely favor ASML and hyperscalers over the funds' mature-value and pharma components.

Key Decisions for Investors

• No directional trade on the article itself; treat it as non-actionable retail content unless Nationwide reports material net inflows or platform-placement data.
• Maintain ASML as the actionable look-through exposure only if semiconductor equipment order commentary confirms 2027 EUV demand; use a 3-6 month long ASML / short EFA pair to limit broad international-equity beta. Falsify on lowered system shipment guidance or adverse export-control action.
• For a quality/value rotation expression over 1-3 months, prefer long UNH and CSCO versus short QQQ rather than allocating to NWAMX; target a 5-8% relative move, with a stop if long-duration rates fall sharply and QQQ outperforms by 5%.
• Avoid using the quantum-computing promotional references as a catalyst for QUBT or hyperscalers; there is no disclosed revenue, contract, or capex signal. Reassess only on independently verifiable bookings or material cloud-service announcements.